SCHEMBL845042

SCHEMBL845042

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3nccn3Cc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1nccn1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PABPC1 P11940 1/20 0.44
HSD17B10 Q99714 1/20 0.43
KDM1A O60341 1/20 0.43
RCOR1 Q9UKL0 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
FKBP1A P62942 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046734 0.89 KDM4E (0.48) ALDH1A1KDM4ELMNARAB9ANPC1
SCHEMBL845176 0.82 CYP2C9 (0.43) ALDH1A1NPC1PABPC1CYP2C9CYP2C19
SCHEMBL845300 0.78 CYP2C9 (0.54) ALDH1A1PABPC1CYP2C9CYP2C19MAPK1
SCHEMBL13272391 0.78 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL845346 0.78 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL845048 0.78 DGAT1 (0.50) ALDH1A1KDM4ELMNARAB9ANPC1
SCHEMBL845226 0.77 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL15116912 0.77 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL845111 0.77 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL845205 0.77 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAPABPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed